Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment

@article{Martins2014CandidiasisPF,
  title={Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment},
  author={N. Martins and I. Ferreira and L. Barros and S{\'o}nia Silva and M. Henriques},
  journal={Mycopathologia},
  year={2014},
  volume={177},
  pages={223-240}
}
Candidiasis is the most common opportunistic yeast infection. Candida species and other microorganisms are involved in this complicated fungal infection, but Candida albicans continues to be the most prevalent. In the past two decades, it has been observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, not only in immunocompromised patients, but also related to nosocomial infections and even in healthy individuals. There is a widely variety of causal factors… Expand
Clinical Appearance of Oral Candida Infection and Therapeutic Strategies
TLDR
The treatment after confirmation of the diagnosis of oral candida infections should include recognizing and eliminating the underlying causes such as ill-fitting oral appliances, history of medications, immunological and endocrine disorders, nutritional deficiency states and prolonged hospitalization. Expand
Clinical Manifestations of Candidiasis: Beyond Candida albicans
TLDR
Treatment of candidiasis rely on three principal antifungal agents; azoles, polyenes, and echinocandins; these three drug classes have specific drug target. Expand
Predisposing factors endorsing Candida infections.
  • Shweta Singh, Z. Fatima, S. Hameed
  • Medicine
  • Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
  • 2015
TLDR
The need to understand the various predisposing factors leading to Candidal infections is established and the various factors discussed on a common platform are discussed. Expand
Diagnosis and treatment of mucosa Candida spp . infections – a review
Candida albicans is the most common cause of fungal infections worldwide. Non-albicans Candida species play an important role in vulvovaginal candidiasis and invasive infections. Most cases ofExpand
Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update.
TLDR
The present review highlights the etiology, epidemiology, molecular typing, commensalism and virulence factors, along with the appropriate prevention and control strategies regarding this widespread pathogen. Expand
Clinical and pathogenicity aspects of Candida species
Candida species normally exist as commensals of the skin and mucosa, but they are also opportunistic pathogens, with the ability to cause a variety of superficial and invasive diseases. Among theExpand
Infection control measures to prevent hospital transmission of candida
TLDR
Infection control measures to prevent hospital transmission of candida are very important and compliance with hand hygiene before and after contact with the patient is the most important step to prevent the spreading of Candida spp. Expand
The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis?
TLDR
The results of the review show that DM patients have an increased susceptibility to Candida sp. Expand
Espèce Candida : l ' ennemi silencieux
Candida species are known to cause serious infections in immunocompromised patients but uncommon cases have been reported in immunocompetent individuals regardless of the harmless co-existence of theExpand
The Antifungal Potential of Stevia rebaudiana Bertoni Leaf Extract Against Candida albicans
TLDR
The aim of this review article is to explain antifungal potency of Stevia rebaudiana Bertoni leaves extracts toward Candida albicans. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 145 REFERENCES
Management of Candida species infections in critically ill patients.
TLDR
This review focuses on the management of invasive deep-seated candidiasis in critically ill, non-immunocompromised patients, and azole prophylaxis is effective and is not associated with acquisition of resistance; it must be restricted to highly selected groups of patients at high risk only. Expand
Management of candidiasis Management of Candida species infections in critically ill patients
TLDR
This review focuses on the management of invasive deep-seated candidiasis in critically ill, non-immunocompromised patients, and azole prophylaxis is effective and is not associated with acquisition of resistance; it must be restricted to highly selected groups of patients at high risk only. Expand
[Invasive fungal infection in immunocompromised patients].
TLDR
The aim of this work is to review the IFIs caused by common and emerging fungi in the three more numerous groups of immunocompromised patients: HIV-infected patients, solid organ transplant recipients and cancer patients, especially those with hematological malignancies or hematopoietic stem-cell transplantation. Expand
The epidemiology of hematogenous candidiasis caused by different Candida species.
TLDR
There has been a substantial shift in the epidemiology of hematogenous candidiasis caused by different Candida species in recent years, and fluconazole appears to be playing a major role in this observed shift. Expand
Candida albicans, a major human fungal pathogen
TLDR
This review will provide a brief overview of the importance of C. albicans as a public health issue, the experimental tools developed to study its fascinating biology, and some examples of how these have been applied. Expand
Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.
TLDR
Reports of resistance to systemic agents, particularly in patients needing recurrent therapy, are increasing, and Amphotericin B, long used as an intravenous agent, is now available as an oral suspension that may offer therapeutic benefits comparable to those of systemic therapy without the toxicity associated with systemic absorption. Expand
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.
TLDR
The epidemiology of invasive candidiasis in non-immunocompromised, critically ill patients with special emphasis on disease trends over time, pathophysiology, diagnostic approach, risk factors, and impact is reviewed. Expand
Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
TLDR
It is the hypothesis that a genomic comparison between these two closely-related species will help to identify virulence factors responsible for the far greater virulence of C. albicans and possibly identify factors that are specifically implicated in either superficial or systemic candidal infections. Expand
Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
TLDR
The outcome in patients with candidemia caused by Candida albicans and Candida non-albicans was poor and the identified risk factors may help to differentiate fatal candidemia in early infection. Expand
Mixed oropharyngeal candidiasis due toCandida albicans and non-albicans Candida strains in HIV-infected patients
TLDR
It is concluded that non-albicans strains ofCandida, less sensitive to azole drugs than theirCandida albicans counterparts, are not clinically relevant in episodes of mixed oropharyngeal candidiasis in HIV-1-infected patients. Expand
...
1
2
3
4
5
...